Patents Assigned to SastoMed GmbH
  • Publication number: 20140221944
    Abstract: The present invention refers to a composition, comprising hemoglobin or myoglobin, wherein in at least 40% of said hemoglobin or myoglobin the oxygen binding site is charged by a non-O2 ligand, and at least one further ingredient, a method for preparing said composition and the use of hemoglobin or myoglobin charged with a non-oxygen ligand for external treatment of wounds.
    Type: Application
    Filed: July 23, 2012
    Publication date: August 7, 2014
    Applicant: SastoMed GmbH
    Inventors: Michael Sander, Harald Potzschke